Search research articles
Contact Us
Filters
Showing results (51-60 of 372) with videos related to
Page
of 38
Sort By:
Leukemia & Lymphoma
|
December 29, 2004
Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma
Stephane Depil, Xavier Leleu, Jean-Baptiste Micol, et al.
Blood
|
August 15, 2002
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy
Philippe Moreau, Thierry Facon, Xavier Leleu, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 13, 2022
Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort
Emilie Chalayer, Alexis Talbot, Laurent Frenzel, et al.
Expert Opinion on Emerging Drugs
|
March 16, 2007
Emerging drugs in multiple myeloma
Irene M Ghobrial, Xavier Leleu, Evdoxia Hatjiharissi, et al.
European Journal of Haematology
|
May 18, 2023
Survival outcomes for patients with multiple myeloma in France: A retrospective cohort study using the Système National des Données de Santé national healthcare database
Xavier Leleu, Boris Gorsh, Antoine Bessou, et al.
Leukemia & Lymphoma
|
September 18, 2008
Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant
Ana B Oton, Hong Wang, Xavier Leleu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 6, 2018
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma
Xavier Leleu, Thomas G Martin, Hermann Einsele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma
Hashem Younes, Xavier Leleu, Evdoxia Hatjiharissi, et al.
The Journal of Rheumatology
|
November 3, 2012
Osteolytic lesion with thick sclerotic walls and demyelinating polyneuropathy
Alexandra Forestier, Guillaume Lefebvre, Xavier Leroy, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 1, 2023
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis
Salomon Manier, Meletios Dimopoulos, Cyrille Hulin, et al.
Page
of 38
Search research articles
Search
Showing results (51-60 of 372) with videos related to
Sort By:
Page
of 38
Leukemia & Lymphoma
|
December 29, 2004
Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma
Stephane Depil, Xavier Leleu, Jean-Baptiste Micol, et al.
Blood
|
August 15, 2002
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy
Philippe Moreau, Thierry Facon, Xavier Leleu, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 13, 2022
Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort
Emilie Chalayer, Alexis Talbot, Laurent Frenzel, et al.
Expert Opinion on Emerging Drugs
|
March 16, 2007
Emerging drugs in multiple myeloma
Irene M Ghobrial, Xavier Leleu, Evdoxia Hatjiharissi, et al.
European Journal of Haematology
|
May 18, 2023
Survival outcomes for patients with multiple myeloma in France: A retrospective cohort study using the Système National des Données de Santé national healthcare database
Xavier Leleu, Boris Gorsh, Antoine Bessou, et al.
Leukemia & Lymphoma
|
September 18, 2008
Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant
Ana B Oton, Hong Wang, Xavier Leleu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 6, 2018
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma
Xavier Leleu, Thomas G Martin, Hermann Einsele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 4, 2007
Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma
Hashem Younes, Xavier Leleu, Evdoxia Hatjiharissi, et al.
The Journal of Rheumatology
|
November 3, 2012
Osteolytic lesion with thick sclerotic walls and demyelinating polyneuropathy
Alexandra Forestier, Guillaume Lefebvre, Xavier Leroy, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 1, 2023
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis
Salomon Manier, Meletios Dimopoulos, Cyrille Hulin, et al.
Page
of 38